Related Experiment Video

Updated: Sep 9, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion

S D Konduri1, A Tasiou, N Chandrasekar

  • 1Department of Biomedical and Therapeutic Sciences, UIC College of Medicine at Peoria, Illinois 61656, USA.

Clinical & Experimental Metastasis
|July 13, 2001
PubMed

Insights

Human tissue factor pathway inhibitor-2 (TFPI-2) significantly reduces amelanotic melanoma cell invasion. Upregulating TFPI-2 in melanoma cells inhibited their invasive behavior, suggesting a role in cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Human tissue factor pathway inhibitor-2 (TFPI-2), also known as placental protein (PP5), is an extracellular matrix protein with protease inhibitory functions.
  • Previous research indicated reduced TFPI-2 levels during human glioma progression.
  • The role of TFPI-2 in melanoma invasiveness remained largely unexplored.

Purpose of the Study:

  • To investigate the functional role of TFPI-2 in the invasive behavior of amelanotic melanoma cells (C-32).
  • To determine if TFPI-2 expression can modulate melanoma cell invasiveness.

Main Methods:

  • Stable transfection of C-32 amelanotic melanoma cells with a vector expressing TFPI-2.
  • Confirmation of TFPI-2 protein and mRNA upregulation using Western blotting and Northern blotting, respectively.
  • Assessment of invasive and migratory potential using in vitro Matrigel invasion/migration assays.

Main Results:

  • Stably transfected clones exhibited significantly higher levels of both TFPI-2 protein and mRNA compared to parental and vector control cells.
  • In vitro assays demonstrated a marked inhibition of invasive and migratory behavior in TFPI-2-upregulated melanoma cells.
  • Parental and vector control cells showed no detectable levels of TFPI-2.

Conclusions:

  • Upregulation of TFPI-2 significantly reduces the invasive behavior of human amelanotic melanoma cells.
  • This study provides the first evidence for TFPI-2's role in suppressing melanoma cell invasiveness.
  • TFPI-2 represents a potential therapeutic target for mitigating melanoma progression.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...